The last day of operation for Hertfordshire and West Essex ICB was 31 March 2026. The information on this website has not been updated since 31 March 2026. The legacy policies, prescribing recommendations and pathways can be accessed on this website. Find out more

RAG rating
n/a
Document type
Clinical pathways
Place
South and West Hertfordshire
Output type
Clinical Pathways
Pathway
Haematuria Pathway

Haematuria


Pathway Publish Date: October 2024
Pathway Next Review Date: October 2026
 

Haematuria is the presence of red blood cells in the urine. It can either be:

  • Visible haematuria (VH) - also referred to as macroscopic haematuria or gross haematuria
  • Non visible haematuria (NVH) - also known as microscopic haematuria or ‘dipstick positive haematuria’ (1)

Significant haematuria is defined as:

  • Any single episode of VH
  • Any single episode of symptomatic -NVH (in absence of UTI or other transient causes).
  • Persistent asymptomatic -NVH (in absence of UTI or other transient causes). Persistence is defined as 2 out of 3 dipsticks positive for NVH(1)

NICE state (3)

  • Refer people using a suspected cancer pathway referral (for an appointment within 2 weeks) for bladder cancer if they are:
    • Aged 45 and over and have:
      • unexplained visible haematuria without urinary tract infection or
      • visible haematuria that persists or recurs after successful treatment of urinary tract infection, or
      • aged 60 and over and have unexplained non-visible haematuria and either dysuria or a raised white cell count on a blood test

    • Consider non-urgent referral for bladder cancer in people aged 60 and over with recurrent or persistent unexplained urinary tract infection
 
 
 
For further information, please see pathway attached. 
Back